Breaking News, Trials & Filings

Research and Markets Releases COVID 19 Clinical Trials Insight

More than 30 clinical trials are being conducted at the global level, with hundreds of patients enrolled

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Research and Markets has added The “Global Coronavirus COVID 19 Clinical Trials Insight 2020” to its reporting. Number of Drugs in Clinical Trials: >30 Drugs Majority of Drugs in Research Phase: >15 Drugs USA & China Dominating Clinical Trials: >20 Drugs Vaccines Accounts Major Share in Clinical Trials: >10 Vaccines Expected Market Opportunity: >U.S. $ 1 Billion Since the recent outbreak of the virus at the global level, research fields at all l...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters